You have 9 free searches left this month | for more free features.

City

Beijing (1)

Condition

HIV Infections (2)

HIV (1)

Hiv (1)

Overall Status

Not yet recruiting (3)

Recruiting (1)

Sign in for free

Phase

phase 1 (3)

phase 2 (1)

Sponsor

Shanxi Kangbao Biological Product Co., Ltd. (4)

Collaborator

Institute of Pathogen Biology, Chinese Academy of Medical Sciences (3)

Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1)

Intervention

dtg (1)

lipovirtide 10mg (1)

lipovirtide 40mg (1)

lipovirtide 60mg (1)

lipovirtide for injection (1)

lipovirtide injection (1)

lp-98 injection (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (4)

Study Type

Interventional (4)

Lipovirtide

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

HIV Trial (Lipovirtide 10mg, Lipovirtide 40mg, Lipovirtide 60mg)

Not yet recruiting

HIV

Lipovirtide 10mg
+3 more

(no location specified)

Sep 23, 2023

HIV Trial (Lipovirtide for injection)

Not yet recruiting

HIV Infections

Lipovirtide for injection

(no location specified)

Apr 22, 2022

HIV Trial in Beijing (Lipovirtide Injection)

Recruiting

HIV Infections

Lipovirtide Injection

Beijing, Beijing, China

Beijing You'an Hospital, Beijing Medical University

Jul 14, 2021

Hiv Trial (LP-98 injection)

Not yet recruiting

Hiv

LP-98 injection

(no location specified)

Jun 27, 2023